Navigation Links
Jupiter Orphan Therapeutics, Inc. Enters into a Global Licensing Agreement with Murdoch Childrens Research Institute
Date:1/12/2016

Friedreich’s Ataxia is an inherited life-shortening disease that causes progressive damage to the nervous system resulting in those affected becoming increasingly unsteady until they require the use of a wheelchair. There are currently no proven treatments.

Murdoch Childrens’ Professor Martin Delatycki is the head of the largest Friedreich’s Ataxia clinic in the southern hemisphere, and his intellectual input and design of clinical trials is central to the agreement.

The product, JOT101, will be a novel proprietary formulation developed by JOT utilising the active ingredient of resveratrol - a natural compound present in grapes and red wine.

Initial studies done by Murdoch Childrens show that this agent has great promise – it was recently found that resveratrol increases a protein called frataxin, which is deficient in the cells of people with Friedreich’s Ataxia. An open-label clinical trial in Friedreich’s Ataxia patients found that there was improvement of neurological symptoms but there were also adverse side effects that limited dosing, meaning a more appropriate formulation and delivery system must be devised.

“There are no treatments that can slow the inexorable progression of this devastating disease. If we can show that JOT101, an improved formulation of resveratrol, is safe, well-tolerated and slows the progression or even reverses some of the symptoms, this would be a significant advancement for people with Friedreich’s Ataxia,” says Prof Delatycki. “Our collaboration with Jupiter Orphan Therapeutics gives us the greatest chance of achieving this.”

“The Friedreich’s Ataxia Research Alliance (FARA) has supported much of the pre-clinical and clinical research that Prof Delatycki and his team at Murdoch Childrens has advanced on resveratrol. We are excited that Jupiter has a new formulation, JOT101, so that we can overcome some of the existing roadblocks and fully evaluate the potential efficacy of resveratrol,” says Jennifer Farmer, Executive Director of FARA.

Jupiter Orphan Pharmaceuticals, Inc. was recently formed to address rare diseases caused by, or related to, single gene deficiencies.

JOT co-founders Christer Rosén and Claes Wahlestedt, jointly stated: “We are very pleased and excited about working together with Prof Delatycki and the Murdoch Childrens’ team with their vast experience in this area. With the addition of JOT’s scientific, clinical, regulatory and formulation expertise we believe that we can, together with Murdoch Childrens, within a relatively short time frame identify a breakthrough treatment for this very serious disease.”

Media contact:

Caitlin Moore - +61 3 8341 6245 or
Anna Curran - +61 3 9936 6737
+61 400 505 090, , Murdoch Childrens Research Institute
anna(dot)curran(at)mcri(dot)edu(dot)au

Christer Rosén, Jupiter Orphan Therapeutics - +1 561 308-7780
c(dot)rosen(at)jupiterorphan(dot)com

Read the full story at http://www.prweb.com/releases/2016/01/prweb13155181.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Joey D Golf Expands Jupiter, FL Training Headquarters, Adds Indoor Driving Range
2. Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership
3. Pet Groomerie Celebrates Fifth Anniversary of Jupiter Salon
4. Orphan Drugs in Oncology Drug Pipeline Update 2013
5. Drug for rare blood disorder developed at Penn receives orphan drug status from EU
6. From Canada to Haiti: Kelowna Dentists Raise Funds to Ship Supplies to Self-Sustaining Village for Orphans
7. NCI Study Finds Orphan Drug May Extend Mesothelioma Survival, According to Surviving Mesothelioma
8. Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio
9. Buy-one, Give-one Company Smile Squared Partners with The Haiti Orphan Project
10. New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma
11. Orphan Drug Announcement Could Mean New Treatment Option for Mesothelioma Patients, According to Surviving Mesothelioma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology: